Clinical Trial Update: Fontan Udenafil Exercise Longitudinal Assessment Trial [Phase 3]

View source ↗

Summary

Phase 3 Fontan udenafil exercise longitudinal assessment trial in single-ventricle heart disease has completed and results have been posted. The update notes th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Single-ventricle Heart Disease

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Mezzion Pharma Co. Ltd | Conditions: Single Ventricle Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-05-21